Nipro Corp - Company Profile
Powered by 
All the sales intelligence you need on Nipro Corp in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Nipro Corp fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Nipro Corp.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Nipro Corp (Nipro) develops, manufactures, and distributes medical devices, pharmaceuticals, and pharmaceutical packaging. The company’s products include renal products, interventional and anaesthesiology products, injection and infusion products, cardiopulmonary products, double bags, pre-filled syringes, and half-type kits among others. It offers contract manufacturing services of development, manufacturing of drug formulations, inspection, packaging, logistics and distribution services. Nipro also provides glass molding vials, ampoules, syringes, and cartridges; glass tubes for pharmaceuticals; glass-forming machinery; other parts of pharmaceutical packaging including rubber plugs; and glass bulbs for vacuum flasks. The company has sales offices in North America, South America, Europe, Asia, and Africa. Nipro is headquartered in Settsu, Osaka, Japan.
Headquarters
Japan
Address
3-26, Senrioka Shin-Machi, Settsu, Osaka, 566-8510
Website
www.nipro.co.jp
Telephone
81 6 63106804
No of Employees
38,593
Industry
Medical Equipment
Ticker Symbol & Exchange
8086 (TYO)
Revenue (2025)
$4.2B
2.5%
(2025 vs 2024)
EPS
XYZ
Net Income (2025)
XYZ
164%
(2025 vs 2024)
Market Cap*
$1.7B
Net Profit Margin (2025)
XYZ
158.2%
(2025 vs 2024)
* As of and is in US$
Nipro Corp premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Medical-Related | Contract Development and Manufacturing Services | NSE |
| Renal | Citrasate | |
| Dialyzers | Biohole | |
| XYZ | XYZ | |
| XYZ | XYZ | |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Contracts/Agreements | In December, the company along with the Japan Institute for Health Security, the international non-profit organization PATH, and the Institut National de Recherche Biomedicale signed the investment agreement with the Global Health Innovative Technology (GHIT) Fund to develop a Mpox detection test. |
| 2025 | Plans/Strategy | In October, the company agreed to acquire the full stake in G2/Spryte Holdco LLC. |
| 2025 | Contracts/Agreements | In August, the company entered into an agreement with Gentuity LLC and GE Healthcare to expand access to advanced intravascular imaging platform. |
Competitor Comparison
| Key Parameters | Nipro Corp | Fresenius SE & Co KGaA | Chugai Pharmaceutical Co Ltd | Terumo Corp | Kyowa Kirin Co Ltd |
|---|---|---|---|---|---|
| Headquarters | Japan | Germany | Japan | Japan | Japan |
| City | Settsu | Bad Homburg | Chuo-Ku | Shibuya-Ku | Chiyoda-Ku |
| State/Province | Osaka | Hessen | Tokyo | Tokyo | Tokyo |
| No. of Employees | 38,593 | 177,783 | 7,872 | 30,689 | 5,161 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Yoshihiko Sano | Chairman | Executive Board | 2025 | 81 |
| Takeshi Yamazaki | Director; Chief Executive Officer; President | Executive Board | 2023 | 58 |
| Takahiro Oichi | Director; President | Executive Board | 2026 | - |
| Kiyotaka Yoshioka | Director; Senior Managing Director | Executive Board | 2006 | - |
| Sadahiro Kaname | Director; General Manager - Product Development and Technical Sales Division | Executive Board | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer